March 3, 2026Open Access

Safety and feasibility assessment of implantable chest wall venous access port for patients with acute leukemia

Key Points

TIVAP can provide a safe and effective long-term intravenous treatment for acute leukemia.
In patients with acute leukemia, TIVAP demonstrates safety and feasibility for venous access.
Observational analysis of TIVAP supports its use for prolonged intravenous therapy in patients.
The findings may suggest TIVAP as a standard option for managing treatment in acute leukemia cases.

Abstract

Our study shows that TIVAP can provide a safe and effective system for long-term intravenous treatment of patients with acute leukemia. Therefore, TIVAP is another potentially effective and safe option for patients with acute leukemia.

Bookmark

View Full Paper

Cite This Study

Ke et al. (Wed,) studied this question.

synapsesocial.com/papers/69a75be3c6e9836116a24066 https://doi.org/https://doi.org/10.3389/fonc.2026.1749957

Bookmark

View Full Paper